Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss

Patent ExpiryapprovedEnobosarmSemaglutidePositive

AI Analysis

Summary

Veru announced a Notice of Allowance for a U.S. patent covering methods of use for Enobosarm combined with Semaglutide for weight loss applications, strengthening intellectual property protection for the combination therapy.

Outcome Details

Notice of Allowance issued for methods of use patent

Importance:6/10

Sentiment:

0.70

patentintellectual propertyweight losscombination therapy

Related Companies

$VERU

Read the original article

Published by yahoo_finance on August 4, 2026 12:30 PM

Read Original